Sinohealth Technology Holdings Limited (Sinohealth Tech) filed its monthly return for the period ended 31 August 2026, confirming that no changes occurred in either its authorised or issued share capital during the month.

The company’s authorised share capital remains at 2.00 billion ordinary shares with a par value of USD 0.01 each, equivalent to USD 20.00 million. Issued share capital is unchanged at 451.77 million ordinary shares, and Sinohealth Tech continues to hold zero treasury shares.

Management affirmed continued compliance with Hong Kong Stock Exchange public-float requirements. As at 31 August 2026, 15.46 % of issued shares were held by public shareholders, exceeding the minimum threshold stipulated by the Exchange.

No share options were outstanding or exercised during the month, and no warrants, convertible securities, or other equity-linked instruments were in issue. The existing share option scheme, approved on 27 April 2022, still allows for up to 45.00 million new shares to be granted in the future.

With no equity issuance, repurchase, or transfer activity in August, Sinohealth Tech’s capital structure and shareholder base remain unchanged heading into September 2026.